Vitamin D induced up-regulation of keratinocyte growth factor (FGF-7/KGF) in MCF-7 human breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 273, Issue 2, 2000, Pages 675-680

  Lyakhovich, Alex ^a   Aksenov, Nickolai ^a   Pennanen, Pasi ^a   Miettinen, Susanna ^a   Ahonen, Merja H ^a   Syvälä, Heimo ^a   Ylikomi, Timo ^a,b   Tuohimaa, Pentti ^a  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Differentiation; FGF 7; KGF; Microarray; Proliferation; Vitamin D

Indexed keywords

CALCITRIOL; FIBROBLAST GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR; MESSENGER RNA; VITAMIN D;

ARTICLE; BREAST CANCER; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0033899474     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2998     Document Type: Article

References (29)

1. de Laat S. W., Boonstra J., Defize L. H., Kruijer W., van der Saag P. T., Tertoolen L. G., van Zoelen E. J., den Hertog J. Growth factor signalling. Int. J. Dev. Biol. 43:1999;681-691.
2. Rubin J., Osada H., Finch P. W., Taylor W. G., Rudikoff S., Aaronson S. A. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc. Natl. Acad. Sci. USA. 86:1989;802-806.
3. Le Panse R., Bouchard B., Lebreton C., Coulomb B. Modulation of keratinocyte growth factor (KGF) mRNA expression in human dermal fibroblasts grown in monolayer or within a collagen matrix. Exp. Dermatol. 5:1996;108-114.
4. Jacquemier J., Sun Z. Z., Penault-Llorca F., Geneix J., Devilard E., Adelaide J., Birnbaum D. FGF7 protein expression in human breast carcinomas. J. Pathol. 186:1998;269-274.
5. Bansal G. S., Cox H. C., Marsh S., Gomm J. J., Yiangou C., Luqmani Y., Coombes R. C., Johnston C. L. Expression of keratinocyte growth factor and its receptor in human breast cancer. Br. J. Cancer. 75:1997;1567-1574.
6. Zhang L., Kharbanda S., Chen D., Bullocks J., Miller D. L., Ding I. Y., Hanfelt J., McLeskey S. W., Kern F. G. MCF-7 breast carcinoma cells overexpressing FGF-1 form vascularized, metastatic tumors in ovariectomized or tamoxifen-treated nude mice. Oncogene. 15:1997;2093-2108.
7. Liu. J. F., Chevet E., Kebache S., Lemaitre G., Barritault D., Larose L., Crepin M. Functional Rac-1 and Nck signaling networks are required for FGF-2-induced DNA synthesis in MCF-7 cells. Oncogene. 18:1999;6425-6433.
8. Byrne R. L., Leung H., Neal D. Peptide growth factors in the prostate as mediators of stromal epithelial interaction. Br. J. Urol. 77:1996;627-633.
9. Reynolds L. P., Killilea S. D., Redmer D. A. Angiogenesis in the female reproductive system. FASEB J. 6:1992;886-892.
10. Miller G. Vitamin D and prostate cancer: Biologic interactions and clinical potentials. Cancer Metastasis Rev. 17:1998;353-360.
11. Fasciana C., van der Made A. C., Faber P. W., Trapman J. Androgen regulation of the rat keratinocyte growth factor (KGF/FGF7) promoter. Biochem. Biophys. Res. Commun. 220:1996;858-863.
12. Chedid M., Rubin J. S., Csaky K. G., Aaronson S. A. Regulation of keratinocyte growth factor gene expression by interleukin 1. J. Biol. Chem. 269:1994;10753-10757.
13. Kueng W., Silber E., Eppenberg U. Quantification of cells cultured on 96-well plates. Anal. Biochem. 182:1989;16-19.
14. Nolan E., Donepudi M., VanWeelden K., Flanagan L., Welsh J. Dissociation of vitamin D3 and anti-estrogen mediated growth regulation in MCF-7 breast cancer cells. Mol. Cell. Biochem. 188:1998;13-20.
15. Haugen J. D., Pittelkow M. R., Zinsmeister A. R., Kumar R. 1 alpha,25-dihydroxyvitamin D3 inhibits normal human keratinocyte growth by increasing transforming growth factor beta 2 release. Biochem. Biophys. Res. Commun. 229:1996;618-623.
16. Musiol I. M., Feldman D. 1,25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: Effect of vitamin D receptor regulation and potency of vitamin D3 analogs. Endocrinology. 138:1997;12-18.
17. Veenstra T. D., Fahnestock M., Kumar R. An AP-1 site in the nerve growth factor promoter is essential for 1, 25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts. Biochemistry. 37:1998;5988-5994.
18. Wilson S. E., Weng J., Chwang E. L., Gollahon L., Leitch A. M., Shay J. W. Hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), and their receptors in human breast cells and tissues: Alternative receptors. Cell Mol. Biol. Res. 40:1994;337-350.
19. Dahiya R., Lee C., Haughney P. C., Chui R., Ho R., Deng G. Differential gene expression of transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines. Urology. 48:1996;963-970.
20. Zhang Y., Kulp S. K., Sugimoto Y., Farrar W. B., Brueggemeier R. W., Lin Y. C. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells. Anticancer Res. 18:1998;2541-2546.
21. Kiguchi K., Beltran L., Rupp T., DiGiovanni J. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol. Mol. Carcinog. 22:1998;73-83.
22. Kitsberg D. I., Leder P. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice. Oncogene. 13:1996;2507-2515.
23. Gniadecki R. Activation of Raf-mitogen-activated protein kinase signaling pathway by 1,25-dihydroxyvitamin D3 in normal human keratinocytes. J. Invest. Dermatol. 106:1996;1212-1217.
24. Zhao X. Y., Ly L. H., Peehl D. M., Feldman D. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent. Endocrinology. 138:1997;3290-3298.
25. Chen T. C., Persons K., Liu W. W., Chen M. L., Holick M. F. The antiproliferative and differentiative activities of 1,25-dihydroxyvitamin D3 are potentiated by epidermal growth factor and attenuated by insulin in cultured human keratinocytes. J. Invest. Dermatol. 104:1995;113-117.
26. Jung C. W., Kim E. S., Seol J. G., Park W. H., Lee S. J., Kim B. K., Lee Y. Y. Antiproliferative effect of a vitamin D3 analog, EB1089, on HL-60 cells by the induction of TGF-beta receptor. Leuk. Res. 23:1999;1105-1112.
27. Colston K. W., Perks C. M., Xie P. S., Holly J. M. Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3. J. Mol. Endocrinol. 20:1998;157-162.
28. Botling J., Oberg F., Torma H., Tuohimaa P., Blauer M., Nilsson K. Vitamin D3- and Retinoic Acid-induced Monocytic Differentiation: Interactions between the endogenious Vitamin D3 Receptor, Retinoic Acid Receptors, and Retinoic Acid X Receptors in O-937 cells. Cell Growth Differ. 7:1996;1239-1249.
29. Wieder R., Fenig E., Wang H., Wang Q., Paglin S., Menzel T., Gabrilove J., Fuks Z., Yahalom J. Overexpression of basic fibroblast growth factor in MCF-7 human breast cancer cells: lack of correlation between inhibition of cell growth and MAP kinase activation. J. Cell. Physiol. 177:1998;411-425.